PIXTECH INC /DE/
10-Q, 2000-11-13
COMPUTER TERMINALS
Previous: PIXTECH INC /DE/, S-8, EX-23.1, 2000-11-13
Next: PIXTECH INC /DE/, 10-Q, EX-27, 2000-11-13



                                    FORM 10-Q
                                    ---------

                       SECURITIES AND EXCHANGE COMMISSION

                             WASHINGTON, D.C. 20549

 (X) QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
                                   ACT OF 1934
               For the quarterly period ending September 30, 2000

                                       OR

( ) TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
                                   ACT OF 1934

                     For the transition period from ______ to ______
                     Commission file number 0-26380
                     _______________________________________________


                                  PIXTECH, INC.
--------------------------------------------------------------------------------
             (Exact name of registrant as specified in its charter)

             Delaware                                      04-3214691
--------------------------------------------------------------------------------
   (State or other jurisdiction of             (IRS Employer Identification No.)
    incorporation or organization)

Avenue Olivier Perroy, 13790 Rousset, France
2700 Augustine Drive, Suite 255, Santa Clara, CA                 95054
--------------------------------------------------------------------------------
(Address of principal executive offices)                       (Zip code)



                              011-33-4-42-29-10-00
--------------------------------------------------------------------------------
              (Registrant's telephone number, including area code)


Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the  preceding  12  months  (or  for such shorter period that the registrant was
required  to  file  such  reports),  and  (2)  has  been  subject to such filing
requirements  for  the  past  90  days.  Yes X   No
                                             -      -

The number of shares outstanding of each of the issuer's classes of Common Stock
as  of

            Class                               Outstanding at November 10, 2000
            -----                               --------------------------------
 Common Stock, $.01 par value                            55,249,857


--------------------------------------------------------------------------------
<PAGE>
<TABLE>
<CAPTION>
                                        PIXTECH, INC.
                                (A DEVELOPMENT STAGE COMPANY)

                                       PIXTECH, INC.
                                       -------------

                                    TABLE OF CONTENTS
                                    -----------------

                                                                                 PAGE NO.
                                                                                 --------
<S>                                                                              <C>
PART I  FINANCIAL INFORMATION

        ITEM 1   Financial Statements

                 Condensed Consolidated Balance Sheets as of September 30, 2000
                 and December 31, 1999. . . . . . . . . . . . . . . . . . . . . . .   3

                 Condensed Consolidated Statements of Comprehensive Operations
                 for the Three-Month Ending September 30, 2000 and 1999, for the
                 Nine-Month Ending September 30, 2000 and 1999, and the period
                 from June 18, 1992 (date of inception) through September 30, 2000.   4
                 Condensed Consolidated Statements of Cash Flows for the Nine-
                 Month ending September 30, 2000 and 1999, and the period from
                 June 18, 1992 (date of inception) through September 30, 2000. . .    5

                 Condensed Consolidated Statements of Stockholders' Equity. . . . .   6

                 Notes to Condensed Consolidated Financial Statements. . . . . .    7 - 10

                 Management's Discussion and Analysis of Financial Condition and
        ITEM 2   Results of Operations. . . . . . . . . . . . . . . . . . . . .    11 - 14

        ITEM 3   Quantitative and Qualitative Disclosures Regarding Market Risk. .    14

PART II OTHER INFORMATION

        ITEM 2   Changes in Securities. . . . . . . . . . . . . . . . . . . . . . .   15

        ITEM 6   Exhibits and Reports on Form 8-K. . . . . . . . . . . . . . . . .    16

Signature . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .   17
Exhibit Index . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .   18
</TABLE>


                                        2
--------------------------------------------------------------------------------
<PAGE>
<TABLE>
<CAPTION>
                                        PIXTECH, INC.
                                (A DEVELOPMENT STAGE COMPANY)

                            CONDENSED  CONSOLIDATED  BALANCE  SHEETS
                            (IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)
                                                                         SEPTEMBER    DECEMBER
                                                                            30,         31,
                                                                           2000         1999
                                                                        -----------  -----------
                                                                        (UNAUDITED)
<S>                                                                     <C>          <C>
                              ASSETS
Current assets :
    Cash and cash equivalents available. . . . . . . . . . . . . . . .  $   21,331   $   14,663
    Restricted cash - short term . . . . . . . . . . . . . . . . . . .         833        1,667
    Accounts receivable:
       Trade . . . . . . . . . . . . . . . . . . . . . . . . . . . . .          71           57
       Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . .         283          709
    Inventories :
        Raw Materials  . . . . . . . . . . . . . . . . . . . . . . . .       1,079        1,109
        Finished Goods . . . . . . . . . . . . . . . . . . . . . . . .         105           --
    Other. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .         681          651
                                                                        -----------  -----------
            Total current assets . . . . . . . . . . . . . . . . . . .      24,383       18,856
Restricted cash - long term  . . . . . . . . . . . . . . . . . . . . .         625        5,833
Property, plant and equipment, net . . . . . . . . . . . . . . . . . .      19,933       24,933
Goodwill, net. . . . . . . . . . . . . . . . . . . . . . . . . . . . .          24           78
Deferred tax assets  . . . . . . . . . . . . . . . . . . . . . . . . .          --        1,255
Other assets - long term . . . . . . . . . . . . . . . . . . . . . . .          46          214
                                                                        -----------  -----------
            Total assets . . . . . . . . . . . . . . . . . . . . . . .  $   45,011   $   51,169
                                                                        ===========  ===========

          LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities :
    Current portion of long term debt . . . . . . . . . . . . . . . . . $    1,290   $    8,128
    Current portion of capital lease obligations. . . . . . . . . . . .        246        2,455
    Accounts payable. . . . . . . . . . . . . . . . . . . . . . . . . .      6,961        7,548
    Accrued expenses. . . . . . . . . . . . . . . . . . . . . . . . . .      2,286        2,135
                                                                        -----------  -----------
            Total current liabilities                                       10,783       20,266
Deferred revenue . . . . . . . . . . . . . . . . . . . . . . . . . . .         546          248
Long term debt, less current portion . . . . . . . . . . . . . . . . .       2,790        3,075
Capital lease obligation, less current portion . . . . . . . . . . . .       5,669        7,644
Other long term liabilities, less current portion. . . . . . . . . . .          35           52
                                                                        -----------  -----------
            Total liabilities. . . . . . . . . . . . . . . . . . . . .      19,823       31,285
                                                                        ===========  ===========
STOCKHOLDERS' EQUITY
    Convertible preferred stock Series E, $0.01 par value, authorized
shares-1,000,000 ; issued and outstanding shares-22,095 and 297,269
respectively . . . . . . . . . . . . . . . . . . . . . . . . . . . . .           1            3
    Common Stock, $0.01 par value, authorized shares-100,000,000
and 60,000,000 respectively; issued and outstanding shares-55,249,857
and 37,351,283 respectively  . . . . . . . . . . . . . . . . . . . . .         552          373
    Additional paid-in capital  .. . . . . . . . . . . . . . . . . . .     131,511      105,081
    Cumulative other comprehensive income  . . . . . . . . . . . . . .      (4,112)      (2,988)
    Deficit accumulated during development stage  .. . . . . . . . . .    (102,764)     (82,585)
                                                                        -----------  -----------
        Total stockholders' equity  .. . . . . . . . . . . . . . . . .      25,188       19,884
                                                                        -----------  -----------
        Total liabilities and stockholders' equity  .. . . . . . . . .  $   45,011   $   51,169
                                                                        ===========  ===========
</TABLE>

                                  See accompanying notes.


                                        3
--------------------------------------------------------------------------------
<PAGE>
<TABLE>
<CAPTION>
                                        PIXTECH, INC.
                                (A DEVELOPMENT STAGE COMPANY)

      CONDENSED  CONSOLIDATED  STATEMENTS  OF  COMPREHENSIVE  OPERATIONS
              (IN  THOUSANDS,  EXCEPT  PER  SHARE  AMOUNTS)
                                   (UNAUDITED)

                                     ---------------------  -------------------  Period from
                                     ---------------------  ------------------- June 18, 1992
                                          Three Months        Nine Months        (date of
                                     --------------------  --------------------  inception)
                                     Ending September 30,  Ending September 30,   through
                                     --------------------  -------------------- September 30,
                                         2000      1999      2000       1999        2000
                                       --------  --------  ---------  ---------  ----------
<S>                                    <C>       <C>       <C>        <C>        <C>
Revenues
   Cooperation and license revenues    $    --   $    --   $     --   $     --   $  26,449
   Product sales . . . . . . . . . .        --        71        217        410       3,527
   Other revenues. . . . . . . . . .       854       877      4,767      3,191      15,581
                                       --------  --------  ---------  ---------  ----------
      Total revenues . . . . . . . .       854       948      4,984      3,601      45,557
                                       --------  --------  ---------  ---------  ----------
Cost of revenues
   License fees and royalties. . . .       (73)      (82)      (255)      (254)     (2,132)
                                       --------  --------  ---------  ---------  ----------
Gross margin . . . . . . . . . . . .       781       866      4,729      3,347      43,425
                                       --------  --------  ---------  ---------  ----------
Operating expenses
   Research and development:
   Acquisition of intellectual property
   rights. . . . . . . . . . . . . . .      --        --        (57)        --      (5,022)
   Other . . . . . . . . . . . . . . .  (7,013)   (7,210)   (22,727)   (19,413)   (122,436)
                                       --------  --------  ---------  ---------  ----------
                                        (7,013)   (7,210)   (22,784)   (19,413)   (127,458)
   Marketing and sales . . . . . . . .    (269)     (338)      (840)    (1,018)     (8,726)
   Administrative and general
   expenses. . . . . . . . . . . . . .    (645)     (787)    (2,142)    (2,289)    (17,941)
                                       --------  --------  ---------  ---------  ----------
                                        (7,928)   (8,335)   (25,767)   (22,720)   (154,126)
                                       --------  --------  ---------  ---------  ----------
Loss from operations . . . . . . . . .  (7,147)   (7,469)   (21,038)   (19,373)   (110,701)
Other income / (expense)
   Interest income . . . . . . . . . .     389       203      1,001        674       4,649
   Interest expense. . . . . . . . . .    (101)     (447)      (544)    (1,282)     (4,955)
   Foreign exchange (losses) / gains .      (5)      112        327     (1,025)        277
   Other revenues / (expenses) . . . .      57        --         74         --          74
                                       --------  --------  ---------  ---------  ----------
                                           340      (132)       858     (1,633)         45
Loss before income tax benefit . . . .  (6,807)   (7,601)   (20,180)   (21,006)   (110,656)
Income tax benefit . . . . . . . . . .      --        --         --         --       7,893
                                       --------  --------  ---------  ---------  ----------
Net loss . . . . . . . . . . . . . . . $(6,807)  $(7,601)  $(20,180)  $(21,006)  $(102,763)
                                       ========  ========  =========  =========  ==========
   Dividends accrued to holders of
                                       --------  --------  ---------  ---------  ----------
   Preferred Stock . . . . . . . . . .      (9)      (78)      (106)      (377)       (631)
                                       --------  --------  ---------  ---------  ----------
Net loss to holders of Common Stock. . $(6,816)  $(7,679)  $(20,286)  $(21,383)  $(103,394)
                                       ========  ========  =========  =========  ==========

   Net loss per share of Common
   Stock . . . . . . . . . . . . . . . $ (0.12)  $ (0.32)  $  (0.41)  $  (1.10)
                                       ========  ========  =========  =========

   Shares of Common Stock used in
   computing net loss per share. . . .  54,922    23,408     49,089     19,037

   Net loss  . . . . . . . . . . . . . $(6,807)  $(7,601)  $(20,180)  $(21,006)  $(102,763)
   Change in other comprehensive . . .    (308)     (129)    (1,123)      (916)     (4,112)
                                       --------  --------  ---------  ---------  ----------
   income  . . . . . . . . . . . . . .
   Comprehensive net loss. . . . . . . $(7,115)  $(7,730)  $(21,303)  $(21,922)  $(106,875)
                                       ========  ========  =========  =========  ==========

                                   See accompanying notes.
</TABLE>


                                        4
--------------------------------------------------------------------------------
<PAGE>
<TABLE>
<CAPTION>
                                        PIXTECH, INC.
                                (A DEVELOPMENT STAGE COMPANY)

                      CONDENSED  CONSOLIDATED  STATEMENTS  OF  CASH  FLOWS
                             (IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)
                                           (UNAUDITED)

                                                                                     Period from
                                                                                     June 18, 1992
                                                                                       (date of
                                                                  NINE MONTHS ENDING   inception)
                                                                     SEPTEMBER 30,      through
                                                                                     September 30,
                                                                 --------------------  ----------
                                                                   2000       1999        2000
                                                                 ---------  ---------  ----------
<S>                                                              <C>        <C>        <C>
Net loss                                                         $(20,180)  $(21,006)  $(102,763)

Total adjustments to net loss. . . . . . . . . . . . . . . . . .   10,287      9,300      42,915
                                                                 ---------  ---------  ----------
Net cash used in operating activities. . . . . . . . . . . . . .   (9,893)   (11,706)    (59,848)
                                                                 ---------  ---------  ----------

INVESTING ACTIVITIES
Additions to property, plant, and equipment. . . . . . . . . . .   (1,862)      (625)    (22,417)
Reclassification of restricted cash as cash available. . . . . .    6,041      1,299      (1,607)
Additions to intangible assets . . . . . . . . . . . . . . . . .       --         --        (130)
                                                                 ---------  ---------  ----------

Net cash provided by / (used in) investing activities  . . . . .    4,179        674     (24,154)

FINANCING ACTIVITIES
Stock issued . . . . . . . . . . . . . . . . . . . . . . . . . .   19,238      4,179     111,847
Proceeds from long-term borrowings . . . . . . . . . . . . . . .      248         --      18,549
Proceeds from sale leaseback transactions. . . . . . . . . . . .       --         --       2,731
Payments for equipment purchases financed by accounts payable. .       --         --      (3,706)
Repayments of long term borrowing and capital lease obligations    (4,803)    (1,481)    (18,646)
                                                                 ---------  ---------  ----------
Net cash provided by financing activities. . . . . . . . . . . .   14,683      2,698     110,775
                                                                 ---------  ---------  ----------

Effect of exchange rates on cash . . . . . . . . . . . . . . . .   (2,301)       563      (5,443)
                                                                 ---------  ---------  ----------

Net increase / (decrease) in cash and cash equivalents . . . . .    6,668     (7,771)     21,331
Cash and cash equivalents beginning of period  . . . . . . . . .   14,663     10,166          --
                                                                 ---------  ---------  ----------

Cash and cash equivalents end of period. . . . . . . . . . . . . $ 21,331   $  2,395   $  21,331
                                                                 =========  =========  ==========
</TABLE>

                                       See accompanying notes.


                                        5
--------------------------------------------------------------------------------
<PAGE>

                                        PIXTECH, INC.
                                (A DEVELOPMENT STAGE COMPANY)

<TABLE>
<CAPTION>


                                   CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
                                             (IN THOUSANDS, EXCEPT SHARE AMOUNTS)

                                                          Series E               Common  Stock
                                                          --------             -----------------
                                                                                                                   Dividends
                                                                                                                  ------------
                                                                                                                   accrued to
                                                                                                                  ------------
                                                                                                     Additional    holders of
                                                                                                    ------------  ------------
                                                           Shares                Shares               Paid-in      Preferred
                                                          ---------            ----------           ------------  ------------
                                                           Issued     Amount     Issued    Amount     Capital        Stock
                                                          ---------  --------  ----------  -------  ------------  ------------
<S>                                                       <C>        <C>       <C>         <C>      <C>           <C>
BALANCE AT DECEMBER 31, 1996                                                    8,141,146  $    81  $    34,085
  Common Stock issued in public offering, net of
issuance costs   -- $796 . . . . . . . . . . . . . . . .                        5,570,819       56       22,958
  Issuance of Common Stock under stock option plan                                 50,767        1           25
  Translation adjustment . . . . . . . . . . . . . . . .
  Net loss-Year ending Dec.  31, 1997 . . . . . . . . . .
BALANCE AT DECEMBER 31, 1997 . . . . . . . . . . . . . .                       13,762,732  $   138  $    57,067

  Common Stock issued in private placements,
net of issuance costs  -- $44 . . . . . . . . . . . . .                         1,236,222       12        4,493
  Issuance of Series E convertible preferred stock,
net of issuance costs -- $822. . . . . . . . . . . . . .   367,269         4                              7,449           (12)
  Issuance of Common Stock under stock option plan                                  1,375                     1
  Translation adjustment . . . . . . . . . . . . . . . .
  Net loss-Year ending Dec. 31, 1998 . . . . . . . . . .
BALANCE AT DECEMBER 31, 1998 . . . . . . . . . . . . . .   367,269   $     4   15,000,329      151       69,012           (12)

  Common Stock issued in private placements . . . . . .                           150,000        1          350
  Issuance costs and dividends accrued in relation
to Series E convertible preferred stock
issued in December 1998 . . . . . . . . . . . . . . . .                                                     (36)         (512)
  Conversion of Series E preferred stock . . . . . . . .   (70,000)       (1)   1,114,220       11          (10)
  Issuance of Common Stock in connection with the
acquisition of certain assets of Micron Display, net
of issuance costs -- $511 . . . . . . . . . . . . . . .                         7,133,562       71       14,134
  Issuance of warrants . . . . . . . . . . . . . . . .                                                      297
  Issuance of Common Stock following conversion
 of Sumitomo convertible loan . . . . . . . . . . . . .                           750,000        7        1,081
  Issuance of Common Stock under stock option plan . .                            137,217        1           72
  Issuance of Common Stock in connection with Equity
Line   Kings-bridge,  net of issuance costs -- $176 . .                           624,809        6          818
  Issuance of Common Stock in connection with private
placement,  net of issuance costs -- $36 . . . . . . . .                       12,427,146      124       19,839
  Issuance of Common Stock in connection with Coloray .                           14,000        1           50
  Translation adjustment . . . . . . . . . . . . . . . .
  Net loss-Year ending Dec. 31, 1999 . . . . . . . . . .
BALANCE AT DECEMBER 31, 1999 . . . . . . . . . . . . . .   297,269   $     3   37,351,283  $   373  $   105,606   $      (525)

  Dividends accrued in relation to Series E convertible
preferred stock issued in December 1998 (unaudited) . .                                                                   (91)
  Conversion of Series E preferred stock (unaudited) . .  (275,174)       (3)   4,195,254       42          (38)          552
  Issuance of Common Stock following conversion of
Sumitomo convertible loan (unaudited). . . . . . . . . .                        2,126,246       21        3,890
  Issuance of Common Stock following conversion of
Sumitomo straight loan (unaudited)  . . . . . . . . . .                           385,549        4        2,496
Issuance of Common Stock in connection with
Kingsbridge Equity Line,  net of issuance  Costs
-- $179 (unaudited))  . . . . . . . . . . . . . . . .                           1,572,261       16        4,305
  Issuance of Common Stock in connection with
Coloray (unaudited)  . . . . . . . . . . . . . . . .                               16,000        0           57
  Issuance of Common Stock in connection with
private placement,  net of issuance costs -- $50
(unaudited) . . . . . . . . . . . . . . . . . . . .                             9,320,359       93       14,894
  Issuance of Common Stock under stock option
plan (unaudited) . . . . . . . . . . . . . . . . . .                              282,905        3          365
  Translation adjustment (unaudited) . . . . . . . . .
Net loss-Nine Months ending September 30, 2000
(unaudited) . . . . . . . . . . . . . . . . . . . . . .
BALANCE AT SEPTEMBER  30, 2000 (UNAUDITED) . . . . . . .    22,095   $     1   55,249,857  $   552  $   131,575   $       (64)
--------------------------------------------------------  =========  ========  ==========  =======  ============  ============


                                                                        Deficit
                                                                        -------
                                                            Other       accumu-
                                                          ---------     -------
                                                           Compre-    lated during
                                                          ---------   ------------
                                                           Hensive      develop
                                                          ---------     -------
                                                           Income      ment  stage     Total
                                                          ---------  --------------  ---------
<S>                                                       <C>        <C>             <C>
BALANCE AT DECEMBER 31, 1996 . . . . . . . . . . . . . .  $   (438)  $     (21,629)  $ 12,099
  Common Stock issued in public offering, net of
issuance costs   -- $796 . . . . . . . . . . . . . . . .                               23,014
  Issuance of Common Stock under stock option plan . . .                                   25
  Translation adjustment . . . . . . . . . . . . . . . .    (1,694)                    (1,694)
  Net loss-Year ending Dec.  31, 1997 . . . . . . . . .                    (14,664)   (14,664)
BALANCE AT DECEMBER 31, 1997 . . . . . . . . . . . . . .    (2,132)        (36,293)    18,780

  Common Stock issued in private placements,
net of issuance costs  -- $44 . . . . . . . . . . . . .                                 4,506
  Issuance of Series E convertible preferred stock,
net of issuance costs -- $822  . . . . . . . . . . . . .                                7,440
  Issuance of Common Stock under stock option plan . . .                                    1
  Translation adjustment . . . . . . . . . . . . . . . .       392                        392
  Net loss-Year ending Dec. 31, 1998 . . . . . . . . . .                   (17,863)   (17,863)
BALANCE AT DECEMBER 31, 1998 . . . . . . . . . . . . . .    (1,740)        (54,156)    13,257

  Common Stock issued in private placements . . . . . . .                                 352
  Issuance costs and dividends accrued in relation
to Series E convertible preferred stock
issued in December 1998 . . . . . . . . . . . . . . . . .                                (548)
  Conversion of Series E preferred stock
  Issuance of Common Stock in connection with the
 acquisition of certain assets of Micron Display, net
of issuance costs -- $511 . . . . . . . . . . . . . . . .                              14,205
  Issuance of warrants . . . . . . . . . . . . . . . . .                                  297
  Issuance of Common Stock following conversion
 of Sumitomo convertible loan . . . . . . . . . . . . .                                 1,088
  Issuance of Common Stock under stock option plan . . .                                   73
  Issuance of Common Stock in connection with Equity
Line   Kings-bridge,  net of issuance costs -- $176 . .                                   824
  Issuance of Common Stock in connection with private
placement,  net of issuance costs -- $36 . . . . . . .                                 19,963
  Issuance of Common Stock in connection with Coloray .                                    51
  Translation adjustment . . . . . . . . . . . . . . . .    (1,249)                    (1,249)
  Net loss-Year ending Dec. 31, 1999 . . . . . . . . . .                   (28,428)   (28,428)
BALANCE AT DECEMBER 31, 1999 . . . . . . . . . . . . . .  $ (2,989)  $     (82,584)  $ 19,884

  Dividends accrued in relation to Series E convertible
preferred stock issued in December 1998 (unaudited) . .                                   (91)
  Conversion of Series E preferred stock (unaudited). .                                   553
  Issuance of Common Stock following conversion of
Sumitomo convertible loan (unaudited) . . . . . . . . .                                 3,911
  Issuance of Common Stock following conversion of
Sumitomo straight loan (unaudited) . . . . . . . . . .                                  2,500
Issuance of Common Stock in connection with
Kingsbridge Equity Line,  net of issuance  Costs
-- $179 (unaudited)) . . . . . . . . . . . . . . . . .                                  4,321
  Issuance of Common Stock in connection with
Coloray (unaudited) . . . . . . . . . . . . . . . . . .                                    57
  Issuance of Common Stock in connection with
private placement,  net of issuance costs -- $50
(unaudited) . . . . . . . . . . . . . . . . . . . . . .                                14,987
  Issuance of Common Stock under stock option
plan (unaudited) . . . . . . . . . . . . . . . . . . . .                                  368
  Translation adjustment (unaudited) . . . . . . . . . .    (1,123)                    (1,123)
Net loss-Nine Months ending September 30, 2000
( unaudited)                                                               (20,180)   (20,180)
BALANCE AT SEPTEMBER  30, 2000 (UNAUDITED) . . . . . . .  $ (4,112)  $    (102,764)  $ 25,188
--------------------------------------------------------  =========  ==============  =========
</TABLE>

                             See accompanying notes


                                        6
--------------------------------------------------------------------------------
<PAGE>
                              PIXTECH, INC.
                       (A DEVELOPMENT STAGE COMPANY)

                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                 (ALL AMOUNTS IN THOUSANDS EXCEPT SHARE AMOUNTS)

NOTE  A  -  BASIS  OF  PRESENTATION

The  financial information as of September 30, 2000, and for the three-month and
nine-month  periods ending September 30, 2000 and 1999 is unaudited but includes
all  adjustments,  which are of a normal recurring nature and, in the opinion of
management,  necessary  for  a  fair  presentation of the financial position and
results  of  operations  for  the  presented periods. The accompanying unaudited
condensed  consolidated  financial  statements  have been prepared in accordance
with  generally accepted accounting principles for interim financial information
and  with  the  instructions  to  Form  10-Q  and  Article 10 of Regulation S-X.
Accordingly,  they  do not include all of the information and footnotes required
by  generally  accepted accounting principles for complete financial statements.
Operating results of the three-month and nine-month periods ending September 30,
2000  are not necessarily indicative of the results that may be expected for the
year  ending  December  31,  2000.  For  further  information,  refer  to  the
consolidated  financial  statements  and  footnotes  thereto for the year ending
December  31,  1999  included  in  our Annual Report on Form 10-K filed with the
Securities  and  Exchange  Commission  on  March  28,  2000.


NOTE  B  -  RESTRICTED  CASH

In  August  1997, we provided Unipac Optoelectronics Corp. ("Unipac"), our Asian
manufacturing  partner,  with  a  written bank guaranty in the amount of $10,000
pursuant  to  the  display foundry agreement (the "Foundry Agreement") signed in
May  1997 between Unipac and us in order to implement volume production of field
emission  displays  at  Unipac's  manufacturing facility. We granted the issuing
banks  a security interest in cash and cash equivalents for the same amount. The
pledged cash and cash equivalents have been recorded as short-term and long-term
restricted  cash  on  the  balance  sheet.

In  March  2000,  pursuant  to  an agreement dated December 17, 1999 signed with
Unipac, the guaranty was reduced by $5,000 in consideration of a payment in cash
of  the  same  amount  to  Unipac. Pursuant to the terms of this agreement, this
$5,000 payment will be considered as a prepayment against our future payments to
Unipac concerning the equipment leased by Unipac to us. Consequently, the amount
of  the  security  interest  to the banks was reduced to $1,458 at September 30,
2000  (see  Note  D  -  Capital  Leases).


NOTE  C  -  PROPERTY,  PLANT  AND  EQUIPMENT

Pursuant to the Foundry Agreement, volume FED production equipment was installed
at  Unipac's  facility. That equipment was purchased and funded by Unipac, and a
portion  of it is leased to us. This portion amounted to $9,991 at September 30,
2000.  According  to  Financial Accounting Standard 13, "Accounting for Leases",
this  equipment  was  recorded  as assets under the caption "Property, Plant and
Equipment"  in  the  net amount of $6,418 at September 30, 2000. Depreciation of
$1,314  was  recorded during the nine-month period ending September 30, 2000. As
of  September 30, 2000, the related capital lease obligation amounted to $5,431,
all  recorded  as  long  term  portion.

NOTE  D  -  CAPITAL  LEASES

We  are  party  to certain sale-leaseback transactions for equipment used in our
pilot  production plant in Montpellier and, pursuant to the Foundry Agreement, a
portion  of  volume  field  emission  displays production equipment installed at
Unipac's  facility  is  leased to us. According to Financial Accounting Standard
13,  "Accounting  for  Leases", a capital lease obligation was recorded in 1998.
During  the  nine-month  period  ending  September 30, 2000, the related capital
lease  obligation  was  reduced  by  $5,000 following the prepayment of the same
amount  made in cash to Unipac and amounted to $5,431 at September 30, 2000 (See
Note  B-Restricted  Cash  and  Note  C-Property,  Plant  and  Equipment).


                                        7
--------------------------------------------------------------------------------
<PAGE>
                              PIXTECH, INC.
                       (A DEVELOPMENT STAGE COMPANY)

Future  minimum  payments  under capital lease obligations at September 30, 2000
are  as  follow:

   YEARS ENDING DECEMBER 31,
   2000 . . . . . . . . . . . . . . . . . . . . . . . . . $   151
   2001 . . . . . . . . . . . . . . . . . . . . . . . . .     544
   2002 . . . . . . . . . . . . . . . . . . . . . . . . .     308
   2003 . . . . . . . . . . . . . . . . . . . . . . . . .   3,320
   2004 . . . . . . . . . . . . . . . . . . . . . . . . .   2,273
                                                           -------
   Total minimum payments . . . . . . . . . . . . . . . .   6,596
   Less amount representing interest. . . . . . . . . . .    (681)
                                                           -------
   Present value of minimum capitalized lease payments  .  $5,915
                                                           -------

NOTE  E  -  LONG  TERM  DEBT

     During  the nine-month period ending September 30, 2000, long term debt was
reduced  by  $7,123. The reduction was mainly due to the conversion of long term
debt  into  shares  of  our  Common  Stock.  The  shares  were  converted from a
convertible  note  and  another note issued to Sumitomo Corporation in 1997. The
principal  amounts  due  under  these notes on December 31, 1999 were $3,912 and
$2,500,  respectively  (See  Note  F-Stockholders'  equity).

Long-term  debt  consists  of  certain  loans payable under which future minimum
payments,  at  September  30,  2000,  are  as  follows:

   YEARS ENDING DECEMBER 31,
   2000 . . . . . . . . . . . . . . . . . . . .    $291
   2001 . . . . . . . . . . . . . . . . . . . .     999
   2002 . . . . . . . . . . . . . . . . . . . .   1,060
   2003 . . . . . . . . . . . . . . . . . . . .     174
   2004 . . . . . . . . . . . . . . . . . . . .     254
   2005 . . . . . . . . . . . . . . . . . . . .   1,302
                                                 ------
   Total minimum payments . . . . . . . . . . .  $4,080
                                                 ======

NOTE  F  -  STOCKHOLDERS'  EQUITY

Common  Stock:

In  January and February 2000, we issued an aggregate of 2,126,246 shares of our
Common  Stock to Sumitomo Corporation upon the conversion in full of $3,912 then
outstanding  under  a  $5,000 convertible note issued in 1997. This note, with a
principal  due  of  $3,912  at  December  31,  1999, was convertible at Sumitomo
Corporation's option into shares of our Common Stock at a conversion price equal
to  80%  of  the  market  price  of  the  Common  Stock  at the conversion date.

In  March 2000, we converted the entire outstanding amount of a loan by Sumitomo
Corporation previously payable in two settlements of $1,250 each in May 2000 and
November  2000  through  the issuance of 385,549 shares of our Common Stock at a
price  of  $6.48  per  share  of Common Stock, for an aggregate consideration of
$2,500.

In  March  2000,  in  connection  with  an agreement signed with Coloray Display
Corporation,  we  issued 16,000 shares of our Common Stock, valued at a price of
$3.57  per  share,  representing  a total amount of $57 in consideration for the
transfer  to  us  of the rights and obligations of Micron Technology, Inc. under
the  license  agreement  dated  as  of  April  8,  1992  between Coloray Display
Corporation  and  Micron  Technology,  Inc.


                                        8
--------------------------------------------------------------------------------
<PAGE>
                              PIXTECH, INC.
                       (A DEVELOPMENT STAGE COMPANY)

In  August  9,  1999,  we  secured  a  $15,000  equity-based line of credit with
Kingsbridge  Capital  Ltd. Under the terms of the equity line, we can draw up to
$15,000  cash  in  exchange for our Common Stock, in increments over a two-years
period.  The  decision to draw on any of the funds and the timing and account of
any  such  draw  are at our sole discretion, subject to certain conditions. Such
conditions  include  limitations depending on the volume and the market price of
our  Common  Stock.  During  the nine-month ending September 30, 2000, we issued
1,572,261  shares of Common Stock, in exchange for $4,321 ($4,500, less issuance
costs  of  $179).  Through  September  30,  2000,  out  of the maximum amount of
$15,000,  we  have  drawn  a  total  amount  of  $5,500.

In  April  2000,  pursuant to an amendment signed in February 2000 to the Common
Stock  Purchase Agreement dated October 6, 1999 with Unipac, we received $15,000
upon  the  completion  of an equity private placement to United Microelectronics
Corporation,  approved  by  the  stockholders  during  a special meeting held on
January  18, 2000. In consideration for this investment, United Microelectronics
Corporation  received  9,320,359 shares at a purchase price of $1.6094 per share
of  Common  Stock.


Convertible  Preferred  Stock:

In  the  nine-month  period ending September 30, 2000, we issued an aggregate of
4,195,254  shares of Common Stock upon the conversion of an aggregate of 275,174
shares  of  Series E Preferred Stock at an average conversion price of $1.60938.
In  September  30,  2000,  there  were 22,095 shares of Series E Preferred Stock
outstanding.  These  shares  of  Series  E Preferred Stock were convertible into
shares  of  Common  Stock  using  a  conversion  price  equal  to  the lesser of
approximately $1.60938 per share of Common Stock or the average closing price of
our  Common  Stock over the ten trading days immediately preceding the notice of
conversion.

The holders of Series E Preferred Stock are entitled to cumulative dividends. In
September  30,  2000  a  dividend  of  $64  was  accrued  and  recorded  against
stockholders' equity.

In  addition,  we  are  required  to reserve, out of the authorized but unissued
shares, 150% of the number of shares of Common Stock that the Series E Stock are
convertible  into.  As of September 30, 2000, the Series E Stock would have been
convertible  into  349,366  shares of Common Stock, thus requiring us to reserve
524,049  shares  of  the  remaining  authorized  but  unissued  shares.


NOTE  G  -  LITIGATION

We have received correspondence from Futaba Corporation and its legal counsel in
January  1998  alleging  the  following;  (i)  PixTech is infringing one or more
patents  owned  by  Futaba  relating  to the construction and manufacture of its
displays  that  are  not  expressly included under the license agreement between
Futaba  and  PixTech,  (ii)  PixTech's  use  of  terms  such  as  "alliance" and
"partners"  in  describing  the  nature  of  its  contractual relationships with
Motorola,  Raytheon  and  Futaba in reports filed with the SEC is misleading and
(iii)  certain  provisions  in  the  Foundry Agreement with Unipac constitute an
impermissible  sublicense  of Futaba technology. Futaba has also claimed that we
improperly  supplied  certain Futaba proprietary information to Unipac, and that
Unipac  has  in turn disclosed such information to a third party vendor. We have
accepted  an  offer of settlement from Futaba, reflected in correspondence dated
December  15,  1999  and  December 30, 1999, pursuant to which Futaba has waived
these  claims  against  us.  We  are  currently  preparing  a definitive written
settlement  agreement  with  Futaba.


NOTE  H-  FINANCIAL  POSITION

During  the  nine-month  period  ending September 30, 2000, we have continued to
experience  losses  and have used cash in operating activities of $9,893.  As of
September  30,  2000,  we  had  a  net  working  deficit of $8,564 and a deficit
accumulated  during  development stage of $102,763. During the nine-month period
ending  September  30,  2000,  we reduced both (i) our long term debt by $6,775,
with the conversion of the Sumitomo Corporation notes issued in 1997 into shares
of  our Common Stock, and (ii) our capital lease obligation mainly in connection
with the prepayment of $5,000 made to Unipac out of our restricted cash. We also
received  $4,321  from  the  Kingsbridge  equity  line.


                                        9
--------------------------------------------------------------------------------
<PAGE>
                              PIXTECH, INC.
                       (A DEVELOPMENT STAGE COMPANY)

NOTE  I-SIGNIFICANT  CONTRACT

On  April 3, 2000, we announced that we have been awarded a development contract
by  DARPA  (Defense  Advanced  Research Projects Agency). Under the terms of the
contract,  PixTech  will  receive approximately $6.3 million for the development
and  demonstration  of  a  full color, full video rate, 12.1-inch Field Emission
Display. After delivery the displays will undergo testing and evaluation for use
in  U.S.  military  vehicles.
This  funding  is  in  addition  to  and  a  continuation  of the existing DARPA
contract,  which  was  transferred  from  Micron  Technology, Inc. to PixTech in
August  of  1999  awarded  for  $4.7  million.


                                       10
--------------------------------------------------------------------------------
<PAGE>
                              PIXTECH, INC.
                       (A DEVELOPMENT STAGE COMPANY)

MANAGEMENT'S  DISCUSSION  AND  ANALYSIS  OF  FINANCIAL  CONDITION AND RESULTS OF
OPERATIONS


This  Management  Discussion  and Analysis of Financial Condition and Results of
Operations  contains  forward-looking statements reflecting management's current
expectation  regarding  our  future financial performance. Such expectations are
based  on  certain  assumptions  and  involve  risks  and  uncertainties.  These
uncertainties  include,  but  are  not  limited  to,  the  risk  associated with
transitioning  to high volume manufacturing of field emission display at Unipac,
product  demand  and market acceptance risks, the commitment of Unipac and/or of
our  licensees, our ability to grant other licenses under field emission display
technology,  the  validity  and  enforceability  of  our patent rights, possible
infringement  by  us  of  patent  rights  of  others,  the impact of competitive
products  and  prices,  product  development  risks,  commercialization  or
technological  delays  or difficulties, trade risks, legal risks, and social and
economic  risks. See also "Important Factors Regarding Future Results" described
more  fully  in Exhibit 99.1 to our Quarterly Report on Form 10-Q filed with the
Securities  and  Exchange  Commission  on  May  15,  2000.


RESULTS  OF  OPERATIONS

     Product  Sales
     We  recognized  product  sales  of $217,000 in the nine-month period ending
September  30,  2000,  as  compared  to $410,000 in the nine-month period ending
September  30,  1999.  During  the  third quarter of 2000, we had no revenues as
compared to $71,000 during the same period last year.  In the nine-month periods
ending  September  30,  1999  and  2000, product revenues primarily consisted of
shipments  of  displays  sold  at volume prices to Zoll Medical.  Since the last
quarter of 1998, we have begun shipping our field emission displays manufactured
by  our  contract  manufacturer, Unipac, to our customers in limited quantities.
During  the three-month period ending September 30, 2000 75% of units shipped to
our  customers  have  been  manufactured in Taiwan, as compared to 7% during the
three-month  period  ending  September  30,  1999.  At  September  30, 2000, 435
displays  were  ready  for  sale and included in finished goods inventory on the
balance  sheet.

     Other  Revenues
     Other  revenues  consist  of  funding  under  various  public  development
contracts  and  other  miscellaneous  revenues.  We recognized other revenues of
$854,000  and  $4,767,000  for the three and nine-month periods ending September
30,  2000,  respectively,  as  compared  to  $877,000 and $3,191,000 in the same
periods  of  1999.  Of these revenues, in the nine-month period ending September
30,  2000,  $4,713,000  was  related  to a development contract awarded to us by
DARPA  (Defense  Advanced  Research  Projects Agency) in August 1999.  Under the
terms  of this DARPA contract, we recognized and received a total amount of $4.7
million,  which  represented the entire amount of this DARPA contract.  In April
2000,  we  began development efforts on a 12.1 inch color field emission display
under  the same DARPA contract of which we have received $2,664,000 in September
30,  2000.  We  announced  the  successful  delivery of the 12.1 inch full color
field  emission  displays to U.S.  Army on August 14, 2000.  The remaining DARPA
funding  as  of  September  30,  2000  that  we  are  entitled  to  receive  is
approximately  $3.6  million,  payable.

     Other  Research  and  Development  Expenses
     We  have  spent $7.0 million and $22.7 million for research and development
during  the  three  and  the  nine-month  periods  ending  September  30,  2000
respectively  as  compared to $7.2 million and $19.4 million in the same periods
of  1999.  The  decrease  for the three-month period is related to a credit note
issued  by  Unipac  to cover the interruptions in the production flow during the
first  quarter  2000, and the favorable impact of the exchange rate between U.S.
dollar  and  Euro  (approximately  $133,000).  However,  the  increase  for  the
nine-month  period  ending  September  30, 2000 includes salaries and associated
expenses  for in-house research and development activities conducted both in our
pilot  plant and our research and development facility in Boise, Idaho. Research
and  development  expenses  include  also the cost of staffing and operating our
pilot  manufacturing  facility  and  the  cost  of  supporting  the transfer and
adaptation  of  our field emission displays technology to Unipac. Obligations to
Commissariat   l'Energie  Atomique  under  the  LETI  Research  Agreement  dated
September  17,  1992  are  also  part of these expenses as well as miscellaneous
consulting  contracts  fees.


                                       11
--------------------------------------------------------------------------------
<PAGE>
                              PIXTECH, INC.
                       (A DEVELOPMENT STAGE COMPANY)

     Sales  and  Marketing  Expenses
     Sales and marketing expenses decreased 21% from $338,000 in the three-month
period  ending  September  30, 1999 to $269,000 in the three-month period ending
September  30,  2000.  We  spent  $840,000  for  sales  and marketing during the
nine-month  period  ending September 30, 2000, compared to $1,018,000 during the
same  period last year.  This variation in sales and marketing expenses reflects
a  change  in  the  reallocation  of  expenses to sales and marketing from other
departments.  However,  we  believe sales and marketing expenses may increase in
the  future,  reflecting  the  expansion of our sales and marketing organization
both  in  the  United  States  and  in  Europe.

     General  and  Administrative  Expenses
     We  spent  $645,000 and $2,100,000 in general and administrative during the
three  and  nine-month periods ending September 30, 2000, respectively, compared
to  $787,000  and $2.200,000 during the same periods in 1999.  This decrease was
attributable  to  a  reduction  in  legal  fees,  consulting  fees  and  other
miscellaneous  expenses  from  the  previous  year.

     Interest  Income  (Expense),  Net
     Interest  income is comprised of interest on available and restricted cash.
Interest expense is comprised of interest payable on long-term obligations.  Net
interest income was $288,000 in the three-month period ending September 30, 2000
and  $457,000  in the nine-month period ending September 30, 2000, compared to a
net  interest  expense  of  $244,000  and  $608,000 in the same periods of 1999,
reflecting the decrease in long-term liabilities, the increase in cash available
and  improved  cash  management  for short term investments on the money market.

     Currency  Fluctuations
     Although  a  significant  portion  of  our revenues are denominated in U.S.
dollars,  a  substantial  portion  of  our operating expenses are denominated in
Euros.  Gains  and  losses  on  the  conversion  to  U.S.  dollars of assets and
liabilities  denominated  in Euros may contribute to fluctuations in our results
of  operations,  which are reported in U.S.  dollars.  Most of our capital lease
obligations  are  expressed  in Taiwanese dollars.  In the past, fluctuations of
the  parity  of  the Taiwanese dollar versus the Euro caused significant foreign
exchange gains or losses and may continue to do so in the future.  We recorded a
net  foreign  exchange loss of $5,000 in the third quarter of 2000 and a gain of
$327,000  in  the nine-month period ending September 30, 2000, compared to a net
foreign  exchange  gain  of  $112,000  and  a loss of $1,025,000 during the same
periods  last  year.  We cannot predict the effect of exchange rate fluctuations
on  future  operating  results.  To  date,  we  have  not  undertaken  hedging
transactions  to  cover  our  currency exposure, but we may do so in the future.

LIQUIDITY  AND  CAPITAL  RESOURCES

Cash  used  in  operations  was $9.8 million during the nine-month period ending
September  30,  2000,  compared to $11.7 million in the nine-month period ending
September  30, 1999. This decrease is primarily a result of significant revenues
received  from  DARPA  (Defense  Advanced Research Projects Agency), from French
Public  Agency  and  from  French  Authorities  during  this  period.

We  have  used  $59.8  million  in  cash  to fund our operations since inception
through  September  30,  2000  and  have  incurred  $24.1  million  in  capital
expenditures  and  investments.

Capital  expenditures  were  $1,862,000  during  the  nine-month  period  ending
September  30,  2000, compared to $625,000 during the same period in 1999. These
capital  expenditures  exclude  assets acquired under capital lease obligations.
During  the  nine-month  period  ending September 30, 2000, capital expenditures
have  remained  focused  on capacity expansion in the Boise, Idaho manufacturing
facility.  Implementing  volume  production  at  Unipac's  manufacturing  plant
required  significant  capital  expenditure.  Pursuant to the Foundry Agreement,
Unipac  funded $14.7 million in capital expenditures for equipment. A portion of
that  equipment  is  leased  to us and the gross amount of this equipment is $10
million as of September 30, 2000. We expect that additional capital expenditures
will  be  required  by  the  end  of 2000 and in 2001, and that we will increase
capacity  at  Unipac and complete implementation of manufacturing processes, for
both  monochrome  and  color  products.


                                       12
--------------------------------------------------------------------------------
<PAGE>
                              PIXTECH, INC.
                       (A DEVELOPMENT STAGE COMPANY)

During  the  nine-month  period  ending  September 30, 2000, restricted cash was
reclassified  as  cash  available in the amount of $6.0 million. Restricted cash
was  related  to  the security interest corresponding to the guaranty granted to
Unipac  in  connection  with  the purchase and funding by Unipac of volume field
emission  displays production equipment. In March 2000, pursuant to an agreement
dated  December  17,  1999  signed with Unipac, the guaranty was reduced by $5.0
million  in  consideration  of  a  payment in cash of the same amount to Unipac.
Pursuant  to  the  terms  of  this  agreement, this $5.0 million payment will be
considered  as a prepayment against our future payments to Unipac concerning the
equipment  leased  by  Unipac  to  us.  Consequently, the amount of the security
interest  to the banks was reduced by the same amount and amounted to $1,458,000
in  September  30,  2000.

Cash  generated  by  financing  activities  were $14.6 million in the nine-month
period  ending  September  30,  2000,  compared to $2.6 million generated in the
nine-month  period  ending  September  30, 1999. This net cash in the nine-month
period  ending  September 30, 2000 consisted of sales of shares of Common Stock,
resulting  in  net  proceeds  of  $19.2  million,  while  repayment of long term
liabilities amounted to $4.8 million, including the $5.0 million prepayment made
to  Unipac.  Cash  generated  from financing activities in the nine-month period
ending  September  30,  2000  excluded  non-cash transactions related to (i) the
conversion into shares of our Common Stock of the convertible loan with Sumitomo
Corporation in the amount of $3.9 million and (ii) the conversion into shares of
our  Common  Stock  of  the loan with Sumitomo Corporation in the amount of $2.5
million,  both  resulting  in  a  decrease  of  our  long term liabilities. Cash
generated  from  financing activities included (i) the sales of shares of Common
Stock  under  the  Kingsbridge  equity  line,  resulting in net proceeds of $4.3
million,  (ii)  the  sale  of  shares  of Common Stock to Unipac, in April 2000,
resulting  in  net  proceeds  of $15.0 million and (iii) the exercise of options
under  the  1993  stock  option plan, resulting in net proceeds of $368,000, but
excluded  non-cash  transactions  related  to the conversion of 275,174 Series E
Convertible  Preferred  Stock  in  March  and  April  2000.

Since  our  inception,  we  have  funded  our operations and capital expenditure
primarily  from  the proceeds of equity financing aggregating $111.8 million and
from proceeds million from borrowings and sale-leaseback transaction aggregating
$21.2.

In  1997  and  January  1999,  we  entered  into  two  research  and development
agreements with French authorities. Under these agreements, we expect to benefit
from  zero-interest  loans  totaling  approximately  $3.0  million,  of which we
received  $482,000  in  April,  2000  and  $2.0  million  in  1999.

In  November  1998,  we  entered  into a research and development agreement with
French authorities.  Under this agreement, we expect to receive a total grant of
approximately  $679,000,  of  which we received $196,000 in 1999 and $367,000 in
the  nine-month  period  ending  September  30,  2000. The $196,000 and $367,000
collected  in  1999  and  in  the  nine-month  period ending September 30, 2000,
respectively,  were not recognized as income as all conditions stipulated in the
agreement  were  not  met.

     On  August 5, 1999, we were awarded a development contract by DARPA.  Under
the  terms  of the contract, we received approximately $4.7 million to develop a
color field emission display of which $3.9 million were received during 2000 and
recognized as income. On April 3, 2000, a new contract, as a continuation of the
existing  contract,  was  signed with DARPA for $6.3 million for the development
and  demonstration  of  a  full color, full video rate, 12.1 inch field emission
display  for  which  to  date,  we  received  $2.6  million.

We  have  recognized French income tax benefits of $7.9 million since inception.
These  income  tax  benefits  represent tax credits for research and development
activities  conducted  in  France,  which  are  paid  in cash to us if it is not
possible  to  credit  them  against  future  income tax liabilities within three
fiscal  years.  In 1998, we collected $2.8 million, representing R&D tax credits
recorded  in  1993  and 1994.  In April 1999, we collected $3.0 million from R&D
tax credit recorded in 1995. We collected $1.1 million in June 2000, in relation
with  the  R&D  tax  credit  recorded  in  1996.

In  August  9, 1999, we secured a $15.0 million equity-based line of credit with
Kingsbridge  Capital  Ltd. Under the terms of the equity line, we can draw up to
$15.0  million  cash  in  exchange  for  our  Common Stock, in increments over a
two-year  period.  The  decision  to draw on any of the funds and the timing and
account  of  any  such  draw  are  at  our  sole  discretion, subject to certain
conditions.  Such conditions include limitations depending on the volume and the
market  price of our Common Stock. During the nine-month period ending September
30, 2000, we issued 1,572,261 shares of Common Stock, resulting in $4,321,000 of
net  proceeds  to  us  ($4.5  million  less issuance costs of $179,000). Through
September  30, 2000, out of the maximum amount of $15.0 million, we have drawn a
total  amount  of  $5.5  million.


                                       13
--------------------------------------------------------------------------------
<PAGE>
                              PIXTECH, INC.
                       (A DEVELOPMENT STAGE COMPANY)

In  January  25,  2000,  we  signed an agreement with Audi and other partners to
jointly  design,  develop,  test  and  deliver  a  7-inches color field emission
display  for  automotive  applications.  This  agreement is part of the European
Commission  IST program. Under the terms of this agreement, the total funding is
approximately  $1.7  million,  of  which  $600,000  are  expected  this  year.

In April 2000, we completed a $15.0 million equity private placement with United
Microelectronics  Corporation.  United  Microelectronics  Corporation  received
9,320,359  million  shares  of  Common  Stock at a purchase price of $1.6094 per
share,  pursuant  to  an amendment, signed in February 2000, to the Common Stock
Purchase  Agreement  dated  October  6,  1999  with  Unipac.

Cash  available  as  of  September 30, 2000 was $21.3 million, compared to $14.7
million  as of December 31, 1999. We expect that cash available on September 30,
2000,  with  the  anticipated proceeds from the Kingsbridge equity-based line of
credit,  and cash from various grants and loans described above and from R&D tax
credits,  will  be sufficient to meet our cash requirements, including repayment
of  the  current  portion  of  our  long-term obligations in the amount of $10.7
million  on  September  30,  2000,  for  the  next  twelve  months.

We  will require substantial funds to conduct research, development and testing,
to  develop  and expand commercial-scale manufacturing systems and to market any
resulting  products. Changes in technology or a growth of sales beyond currently
anticipated  levels  will  also  require  further  investment.  Our  capital
requirements  will  depend  on  many factors, including the rate at which we can
develop  our  products,  the  market  acceptance of such products, the levels of
promotion  and  advertising  required  to  launch  such  products  and  attain a
competitive  position  in the marketplace and the response of competitors to our
products.  We  cannot make assurance that funds for these purposes, whether from
equity  or debt financing, or other sources, will be available when needed or on
terms  acceptable  to  us.


QUANTITATIVE  AND  QUALITATIVE  DISCLOSURES  ABOUT  MARKET  RISK

     The  market  risk exposure inherent to our international operations creates
potential  for  losses arising from adverse changes in foreign currency exchange
rates.  We  are  exposed to such foreign currency exchange rate risk in two main
areas: (i) a substantial portion of our operating expenses are, and are expected
to  be,  denominated  in  Euros,  (ii) most of our capital lease obligations are
expressed  in  Taiwanese  dollars.  Fluctuations  of the parity of the Taiwanese
dollar versus the Euro or the U.S. dollar may cause significant foreign exchange
gains  or  losses.  In addition, gains and losses arising from the conversion to
U.S.  dollars  of  assets  and  liabilities denominated in Euros or in Taiwanese
dollars  may  contribute to fluctuations in our results of operations, which are
reported  in  U.S. dollars. To date, we have not undertaken hedging transactions
to  cover  its  currency exposure. We are also exposed to interest rate risks in
connection  with  certain  long-term debt. We do not, however, enter into market
sensitive  instruments  for  trading  purposes.


                                       14
--------------------------------------------------------------------------------
<PAGE>
                              PIXTECH, INC.
                       (A DEVELOPMENT STAGE COMPANY)

PIXTECH, INC.

PART II  Other Information

         ITEM 2        Changes in Securities:

                            During the three-month period ending September 30,
                       2000  we  issued 368,070 shares  in connection with the
                       $15 million  Kingsbridge equity line of credit  secured
                       in  August  1999,  as  private  placement  exempt  from
                       registration  under Section 4(2) of the Securities Act.
                       These  368,070  shares  of  Common  Stock  resulted  in
                       proceeds  to  us  of $953,000 ($1,000,000 less issuance
                       costs of $47,000).


                                       15
--------------------------------------------------------------------------------
<PAGE>
                              PIXTECH, INC.
                       (A DEVELOPMENT STAGE COMPANY)

     ITEM 6    Exhibits and reports on Form 8-K:

               (a)     Exhibits:
                       --------

                       27. Financial Data Schedule
                       ---------------------------

               (b)     Reports on Form 8-K:
                       -------------------

                       No reports  on  Form  8-K  were  filed during  the  third
                       quarter of 2000.


                                       16
--------------------------------------------------------------------------------
<PAGE>
                              PIXTECH, INC.
                       (A DEVELOPMENT STAGE COMPANY)

PIXTECH, INC.


September  30,  2000


SIGNATURES


Pursuant  to  the  requirements  of  the  Securities  Exchange  Act of 1934, the
registrant  has  duly  caused  this  report  to  be  signed on its behalf by the
undersigned  thereunto  duly  authorized.


                                         PIXTECH,  INC.


Date:  November 10, 2000
                                         BY:  /s/  Marie  Boem
                                            ------------------
                                         Marie  Boem,
                                         Principal  Financial  Officer


                                       17
--------------------------------------------------------------------------------
<PAGE>
                              PIXTECH, INC.
                       (A DEVELOPMENT STAGE COMPANY)

PIXTECH,  INC.


September  30,  2000


EXHIBIT  INDEX


        Exhibit  No.

        27     Financial  Data  Schedule


                                       18
--------------------------------------------------------------------------------
<PAGE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission